Tekla Capital Management LLC Arvinas, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$32.47 - $57.24 $1.4 Million - $2.46 Million
-42,999 Reduced 50.0%
42,998 $1.47 Million
Q1 2021

May 14, 2021
BUY
$58.19 - $91.37 $729,586 - $1.15 Million
12,538 Added 17.07%
85,997 $5.68 Million
Q4 2020

Feb 12, 2021
BUY
$20.19 - $84.93 $1.48 Million - $6.24 Million
73,459 New
73,459 $6.24 Million

Others Institutions Holding ARVN

# of Institutions
222
Shares Held
68.8M
Call Options Held
166K
Put Options Held
31.3K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.44B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email